Dapivirine + Pritelivir + Levonorgestrel 3D Printed IVR
Our paramount innovation is use of digital light synthesis – a novel 3D printing process known as continuous liquid interface production (CLIP™) – for rapid, scalable, and cost-effective manufacturing of geometrically and mechanically tunable, rationally designed intravaginal rings as platforms for multi-drug delivery.
Development Stage:
Preclinical – Early (Pre1)
Hormonal/Non-Hormonal:
Hormonal
Delivery Route & Method:
Intravaginal - Intravaginal Ring (IVR)
Developer:
- University of North Carolina, Chapel Hill
Funding:
- Nat. Institute Allergy & Infect. Diseases (NIAID)
Funding Mechanism:
NIAID: R61
Past Funding:
Eshelman Institute for Innovation (EII)
Active Ingredient(s):
- Dapivirine
- Levonorgestrel
- Pritelivir
Product Indication(s):
- HIV
- HSV-2
- Pregnancy
Useful Links: